SEC 13F Intelligence

Boxer Capital, LLC / LXRX

Boxer Capital, LLC’s Lexicon Pharmaceuticals Inc Position

Does Boxer Capital, LLC own Lexicon Pharmaceuticals Inc (LXRX)? Not currently — the last reported position was 2.77M shares worth $12M in Q4 2019; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$12M
Q4 2019
Shares
2.77M
% of Portfolio
+0.65%
Quarters Held
2
position exited

Position History LXRX

Reported value by quarter
Q3 ’19: $8MQ3 ’19Q4 ’19: $12MQ4 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20192.77M$12M+0.65%
Q3 20192.50M$8M+0.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of LXRX.